FDA user fees
Executive Summary
Are not included in the FY 1991 budget resolution debated on the House floor the week of April 23. The budget blueprint, which sets the general framework for appropriations committees, was adopted by the House Budget Committee April 20 and a House vote is expected in early May. The measure recommends an FDA budget of$624 mil. in FY 1991, which is the Congressional Budget Office's projection of the amount needed to maintain the 1990 level of activity, including an increase for inflation. FDA's 1990 budget is $587 mil. The Bush Administration proposed a $685 mil. budget for fiscal 1991, but with $157 mil. in user fees. The Senate Budget Committee has not yet got around to specific agency budgets.
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.